22.09.2023 • NewsIneosMergers & Acquisitions (M&A)Eramet

Ineos Acquires Eramet Titanium & Iron for €230 Million

Ineos Enterprises has announced the acquisition of Eramet Titanium & Iron (ETI) from Eramet for €230 million ($245 million). The deal was completed on Sept. 21 and takes immediate effect, following the satisfaction of regulatory approvals.

ETI operates an ilmenite transformation plant in Norway producing titanium slag which is used in the pigments industry. It also produces high-purity pig iron sold to European foundries. The agreement between Eramet and Ineos Enterprises also includes a long-term supply contract for ilmenite produced by Grande Côte Opérations (“GCO”), the Group’s subsidiary which operates the mineral sands mine in Senegal. Under Ineos ownership, ETI will now be known as Ineos Tyssedal.

Ashley Reed, CEO Ineos Enterprises commented “We are very pleased to acquire ETI from Eramet. This is a good quality asset, complemented by an experienced operations team. We believe the next phase of ETI’s development can be well progressed under Ineos ownership and further improve the long-term sustainability of the company.”

 

Ineos acquires ETI, including an ilmenite transformation plant in Tyssedal,...
Ineos acquires ETI, including an ilmenite transformation plant in Tyssedal, Norway (pictured), from Eramet for €230 million ($245 million). © Ineos Enterprises

Company

Logo:

Ineos

38 Hans Crescent, Knightsbridge
SW1X 0LZ London
UK

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.